HUM Stock Cash Flow Statements

Humana Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Humana Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31

cash flows from operating activities
net income	543,000,000	1,242,000,000	-683,000,000	480,000,000	678,000,000	739,000,000	-540,000,000	830,000,000	956,000,000	1,238,000,000	-18,000,000	1,193,000,000	697,000,000	930,000,000	-13,000,000	1,531,000,000	588,000,000	828,000,000	-274,000,000	1,340,000,000	1,828,000,000	473,000,000	689,000,000	940,000,000	566,000,000	644,000,000	193,000,000	491,000,000	499,000,000	650,000,000	1,115,000,000	450,000,000	331,000,000	234,000,000	314,000,000	431,000,000	430,000,000	145,000,000	290,000,000	344,000,000	368,000,000	-30,000,000	368,000,000	420,000,000	473,000,000	192,000,000	426,000,000	356,000,000	248,000,000	198,777,000	444,760,000	460,287,000	315,176,000	107,325,000	393,221,000	340,076,000	258,768,000	250,659,000	301,519,000	281,780,000	205,717,000
adjustments to reconcile net income to net cash from operating activities:
gain on investment securities	-11,000,000	-2,000,000
equity in net incomees	19,000,000	43,000,000	37,000,000	16,000,000	17,000,000	24,000,000	24,000,000	12,000,000	10,000,000	17,000,000			-2,000,000	4,000,000
stock-based compensation	61,000,000	49,000,000	54,000,000	53,000,000	55,000,000	45,000,000	33,000,000	53,000,000	51,000,000	38,000,000	43,000,000	80,000,000	50,000,000	43,000,000		48,000,000	45,000,000	39,000,000		47,000,000	46,000,000	36,000,000	43,000,000	43,000,000	33,000,000	36,000,000	34,000,000	35,000,000	33,000,000	57,000,000	26,000,000	28,000,000	25,000,000	23,000,000	23,000,000	25,000,000	44,000,000	22,000,000	21,000,000	22,000,000	33,000,000	19,000,000	22,000,000	19,000,000	32,000,000	14,000,000	14,000,000	14,000,000	40,000,000	14,222,000	11,800,000	11,203,000	29,775,000	10,843,000	12,477,000	12,288,000	27,339,000	17,052,000	15,796,000	17,346,000	15,676,000
depreciation	196,000,000	200,000,000	226,000,000	228,000,000	228,000,000	226,000,000	222,000,000	218,000,000	210,000,000	200,000,000	194,000,000	186,000,000	188,000,000	181,000,000	172,000,000	160,000,000	155,000,000	153,000,000	138,000,000	138,000,000	128,000,000	124,000,000	142,000,000	122,000,000	118,000,000	112,000,000	109,000,000	109,000,000	102,000,000	101,000,000	100,000,000	99,000,000	96,000,000	94,000,000	85,000,000	90,000,000	88,000,000
amortization	15,000,000	15,000,000	14,000,000	15,000,000	15,000,000	16,000,000	16,000,000	17,000,000	16,000,000	18,000,000	23,000,000	28,000,000	21,000,000	24,000,000	22,000,000	21,000,000	15,000,000	15,000,000	22,000,000	23,000,000	22,000,000	21,000,000	17,000,000	18,000,000	18,000,000
impairment of property and equipment	5,000,000	9,000,000	108,000,000	42,000,000	54,000,000	33,000,000	175,000,000
impairment of indefinite-lived intangible assets
changes in operating assets and liabilities, net of effect of businesses acquired and disposed:
receivables	-45,000,000	-1,755,000,000	-560,000,000	1,946,000,000	-165,000,000	-1,890,000,000	-211,000,000	-395,000,000	1,702,000,000	-1,433,000,000	-65,000,000	1,744,000,000	-373,000,000	-1,360,000,000	14,000,000	991,000,000	-236,000,000	-1,049,000,000	-3,000,000	1,103,000,000	-232,000,000	-953,000,000	56,000,000	1,063,000,000	-940,000,000	408,000,000	-197,000,000	-422,000,000	1,508,000,000	-592,000,000	-558,000,000	1,788,000,000	-816,000,000	-576,000,000	1,143,000,000	-443,000,000	-644,000,000	-196,000,000	1,069,000,000	-613,000,000	-524,000,000	-162,000,000	771,000,000	-272,000,000	-588,000,000	-110,000,000	259,000,000	432,000,000	-255,000,000	-28,701,000	510,075,000	-327,045,000	-260,329,000	-61,127,000	517,074,000	-220,504,000	-280,978,000	-66,213,000	500,386,000	-239,041,000	-255,098,000
other assets	28,000,000	-686,000,000	745,000,000	-334,000,000	495,000,000	97,000,000	-383,000,000	206,000,000	-234,000,000	-907,000,000	2,000,000	190,000,000	-27,000,000	-628,000,000	-15,000,000	403,000,000	216,000,000	-1,095,000,000	966,000,000	577,000,000	-654,000,000	-1,470,000,000	882,000,000	-446,000,000	-102,000,000	719,000,000	-494,000,000	-1,164,000,000	176,000,000	-130,000,000	-415,000,000	259,000,000	7,000,000	-685,000,000	357,000,000	-292,000,000	-1,145,000,000	8,000,000	-46,000,000	-348,000,000	-566,000,000	-165,000,000	-57,000,000	22,000,000	-130,000,000	-17,000,000	14,000,000	-112,000,000	-138,000,000	22,092,000	-30,292,000	-63,880,000	-110,920,000	-38,595,000	46,045,000	102,860,000	-29,177,000	100,755,000	30,545,000	43,080,000	-61,907,000
benefits payable	-391,000,000	1,011,000,000	-685,000,000	-321,000,000	-283,000,000	1,488,000,000	45,000,000	-108,000,000	224,000,000	754,000,000	27,000,000	-413,000,000	272,000,000	1,089,000,000	-469,000,000	273,000,000	-166,000,000	466,000,000	-65,000,000	228,000,000	890,000,000	1,086,000,000	378,000,000	-182,000,000	1,162,000,000	0	117,000,000	293,000,000	121,000,000	77,000,000	198,000,000	-209,000,000	144,000,000	138,000,000	141,000,000	17,000,000	289,000,000	-201,000,000	-102,000,000	346,000,000	539,000,000	-178,000,000	-91,000,000	67,000,000	311,000,000	-172,000,000	-39,000,000	-114,000,000	284,000,000	-143,122,000	-84,757,000	13,127,000	470,752,000	-257,605,000	-102,812,000	122,690,000	484,459,000	-142,907,000	-45,716,000	172,698,000	32,920,000
other liabilities	817,000,000	193,000,000	125,000,000	-171,000,000	95,000,000	-422,000,000	802,000,000	209,000,000	68,000,000	-238,000,000	239,000,000	138,000,000	-230,000,000	-103,000,000	-31,000,000	508,000,000	-150,000,000	-151,000,000	-658,000,000	-1,010,000,000	1,064,000,000	1,203,000,000	284,000,000	-132,000,000	16,000,000	-132,000,000	-205,000,000	885,000,000	324,000,000	-225,000,000	542,000,000	-1,071,000,000	-12,000,000	1,210,000,000	-1,063,000,000	-128,000,000	1,051,000,000	175,000,000	-403,000,000	-43,000,000	684,000,000	289,000,000	-28,000,000	-138,000,000	190,000,000	179,000,000	70,000,000	-1,000,000	52,000,000	-197,892,000	189,823,000	-2,107,000	204,176,000	201,123,000	301,608,000	-26,905,000	246,068,000	24,363,000	87,766,000	-120,822,000	22,375,000
unearned revenues	9,000,000	5,000,000	65,000,000	-118,000,000	12,000,000	35,000,000	-7,270,000,000	158,000,000	158,000,000	6,934,000,000	-5,726,000,000	5,748,000,000	-24,000,000	34,000,000	19,000,000	-89,000,000	-2,000,000	7,000,000	31,000,000	21,000,000	-8,000,000	27,000,000	-38,000,000	0	29,000,000	-3,336,000,000	-76,000,000	3,328,000,000	91,000,000	-64,000,000	3,140,000,000	3,040,000,000	-49,000,000	-4,000,000	6,000,000	-87,000,000	17,000,000	115,000,000	-2,000,000	-15,000,000	57,000,000	8,000,000	5,000,000	-50,000,000	13,000,000	52,000,000	-2,172,000,000	43,000,000	2,034,000,000	-1,793,931,000	1,800,482,000	-14,145,000	33,594,000	-31,160,000	4,398,000	-26,238,000	6,767,000	9,028,000	-25,066,000	3,393,000	3,364,000
other		7,000,000	32,000,000	32,000,000	11,000,000	33,000,000	60,000,000	17,000,000	30,000,000	6,000,000	40,000,000	-1,000,000	19,000,000	12,000,000	26,000,000	29,000,000	4,000,000	-19,000,000	24,000,000	28,000,000	10,000,000	-13,000,000	8,000,000	27,000,000	18,000,000	27,000,000	23,000,000	47,000,000	47,000,000	31,000,000	36,000,000	49,000,000	36,000,000	32,000,000	14,000,000	20,000,000	18,000,000	14,000,000	12,000,000	16,000,000	0	49,000,000	16,000,000	14,000,000	14,000,000	28,000,000	19,000,000	16,000,000	16,000,000	16,586,000	14,305,000	15,798,000	14,311,000	13,244,000	11,607,000	11,441,000	8,205,000	2,166,000	4,905,000	5,967,000	5,815,000
net cash from operating activities	1,271,000,000	331,000,000	-528,000,000	1,858,000,000	1,213,000,000	423,000,000	-7,134,000,000	1,252,000,000	3,176,000,000	6,687,000,000	-5,127,000,000	8,453,000,000	959,000,000	302,000,000	-96,000,000	2,835,000,000	360,000,000	-837,000,000	283,000,000	1,815,000,000	3,067,000,000	474,000,000	2,442,000,000	1,434,000,000	896,000,000	-1,055,000,000	-125,000,000	3,686,000,000	2,863,000,000	-106,000,000	4,205,000,000	4,503,000,000	-276,000,000	482,000,000	1,032,000,000	-608,000,000	107,000,000	193,000,000	954,000,000	-200,000,000	671,000,000	-16,000,000	1,147,000,000	173,000,000	412,000,000	205,000,000	-1,334,000,000	706,000,000	2,346,000,000	-1,796,980,000	2,919,315,000	161,213,000	795,452,000	-47,377,000	1,209,209,000	325,311,000	754,651,000	274,091,000	940,111,000	161,860,000	45,520,000
capex	-114,000,000	-95,000,000	-154,000,000	-130,000,000	-114,000,000	-177,000,000	-283,000,000	-234,000,000	-264,000,000	-223,000,000	-258,000,000	-288,000,000	-279,000,000	-295,000,000	-371,000,000	-326,000,000	-329,000,000	-290,000,000	-296,000,000	-250,000,000	-226,000,000	-192,000,000	-210,000,000	-157,000,000	-139,000,000	-164,000,000	-138,000,000	-134,000,000	-143,000,000	-111,000,000	-122,000,000	-139,000,000	-131,000,000	-125,000,000	-125,000,000	-136,000,000	-123,000,000	-167,000,000	-145,000,000	-110,000,000	-106,000,000	-131,000,000	-123,000,000	-97,000,000	-90,000,000	-106,000,000	-119,000,000	-99,000,000	-86,000,000	-130,074,000	-86,745,000	-58,700,000	-70,481,000	-69,870,000	-61,005,000	-52,399,000	-39,028,000	-63,315,000	-39,533,000	-43,555,000	-39,047,000
free cash flows	1,157,000,000	236,000,000	-682,000,000	1,728,000,000	1,099,000,000	246,000,000	-7,417,000,000	1,018,000,000	2,912,000,000	6,464,000,000	-5,385,000,000	8,165,000,000	680,000,000	7,000,000	-467,000,000	2,509,000,000	31,000,000	-1,127,000,000	-13,000,000	1,565,000,000	2,841,000,000	282,000,000	2,232,000,000	1,277,000,000	757,000,000	-1,219,000,000	-263,000,000	3,552,000,000	2,720,000,000	-217,000,000	4,083,000,000	4,364,000,000	-407,000,000	357,000,000	907,000,000	-744,000,000	-16,000,000	26,000,000	809,000,000	-310,000,000	565,000,000	-147,000,000	1,024,000,000	76,000,000	322,000,000	99,000,000	-1,453,000,000	607,000,000	2,260,000,000	-1,927,054,000	2,832,570,000	102,513,000	724,971,000	-117,247,000	1,148,204,000	272,912,000	715,623,000	210,776,000	900,578,000	118,305,000	6,473,000
cash flows from investing activities
acquisitions, net of cash and cash equivalents acquired			-52,000,000	-20,000,000	-3,000,000	-14,000,000	-10,000,000	-34,000,000	-116,000,000	-73,000,000	-44,000,000	-126,000,000	-93,000,000	-74,000,000	-228,000,000
purchases of property and equipment	-114,000,000	-95,000,000	-154,000,000	-130,000,000	-114,000,000	-177,000,000	-283,000,000	-234,000,000	-264,000,000	-223,000,000	-258,000,000	-288,000,000	-279,000,000	-295,000,000	-371,000,000	-326,000,000	-329,000,000	-290,000,000	-296,000,000	-250,000,000	-226,000,000	-192,000,000	-210,000,000	-157,000,000	-139,000,000	-164,000,000	-138,000,000	-134,000,000	-143,000,000	-111,000,000	-122,000,000	-139,000,000	-131,000,000	-125,000,000	-125,000,000	-136,000,000	-123,000,000	-167,000,000	-145,000,000	-110,000,000	-106,000,000	-131,000,000	-123,000,000	-97,000,000	-90,000,000	-106,000,000	-119,000,000	-99,000,000	-86,000,000	-130,074,000	-86,745,000	-58,700,000	-70,481,000	-69,870,000	-61,005,000	-52,399,000	-39,028,000	-63,315,000	-39,533,000	-43,555,000	-39,047,000
purchases of investment securities	-1,114,000,000	-827,000,000	-1,782,000,000	-3,441,000,000	-1,703,000,000	-1,259,000,000	-4,186,000,000	-629,000,000	-1,424,000,000	-1,313,000,000	-1,309,000,000	-1,501,000,000	-1,078,000,000	-2,161,000,000	-624,000,000	-1,266,000,000	-1,587,000,000	-3,720,000,000	-1,895,000,000	-1,766,000,000	-3,005,000,000	-2,459,000,000	-995,000,000	-960,000,000	-2,175,000,000	-755,000,000	-913,000,000	-1,711,000,000	-1,129,000,000	-1,332,000,000	-1,876,000,000	-2,005,000,000	-1,098,000,000	-1,430,000,000	-2,624,000,000	-892,000,000	-829,000,000	-934,000,000	-981,000,000	-461,000,000	-507,000,000	-596,000,000	-1,280,000,000	-602,000,000	-783,000,000	-1,055,000,000	-802,000,000	-650,000,000	-714,000,000	-1,010,647,000	-765,270,000	-715,509,000	-1,186,574,000	-1,006,980,000	-823,184,000	-1,233,819,000	-1,525,349,000	-1,906,188,000	-2,451,044,000	-1,435,869,000	-1,403,906,000
proceeds from maturities of investment securities	728,000,000	889,000,000	768,000,000	859,000,000	710,000,000	645,000,000	407,000,000	308,000,000	310,000,000	267,000,000	151,000,000	267,000,000	359,000,000	588,000,000	494,000,000
proceeds from sales of investment securities	721,000,000	522,000,000	1,618,000,000	1,259,000,000	108,000,000	391,000,000	2,980,000,000	4,000,000	761,000,000	50,000,000	455,000,000	616,000,000	69,000,000	1,294,000,000	627,000,000	499,000,000	468,000,000	1,953,000,000	650,000,000	13,000,000	669,000,000	1,415,000,000	252,000,000	564,000,000	2,062,000,000	206,000,000	1,016,000,000	1,392,000,000	305,000,000	928,000,000	795,000,000	1,466,000,000	939,000,000	914,000,000	1,878,000,000	1,042,000,000	528,000,000	1,238,000,000	164,000,000	889,000,000	118,000,000	485,000,000	253,000,000	662,000,000	192,000,000	510,000,000	365,000,000	287,000,000	242,000,000	633,539,000	193,455,000	278,174,000	153,832,000	713,582,000	207,630,000	546,116,000	545,166,000	1,047,390,000	1,152,495,000	1,029,153,000	722,288,000
changes in securities lending collateral receivable	127,000,000	-175,000,000
net cash from investing activities	347,000,000	314,000,000	-63,000,000	-1,473,000,000	-1,002,000,000	-414,000,000	-882,000,000	-585,000,000	-733,000,000	-1,292,000,000	-1,012,000,000	1,676,000,000	-1,022,000,000	-648,000,000	-102,000,000	-4,251,000,000	-715,000,000	-1,488,000,000	-55,000,000	-148,000,000	-1,652,000,000	-1,210,000,000	-566,000,000	-56,000,000	145,000,000	-2,353,000,000	118,000,000	-405,000,000	-698,000,000	-152,000,000	-926,000,000	-237,000,000	131,000,000	-428,000,000	-605,000,000	1,316,000,000	-94,000,000	305,000,000	-772,000,000	575,000,000	-171,000,000	-39,000,000	-995,000,000	244,000,000	-392,000,000	-1,212,000,000	-414,000,000	-149,000,000	-190,000,000	-214,803,000	-284,348,000	-168,122,000	-690,727,000	-945,919,000	-192,929,000	-144,924,000	-527,217,000	-389,063,000	-1,025,121,000	-188,279,000	-256,798,000
cash flows from financing activities
(payments) receipts from contract deposits	-544,000,000	-35,000,000	-1,295,000,000
proceeds from issuance of senior notes	0	1,481,000,000	0	0	0	2,232,000,000	1,329,000,000	0	0	1,215,000,000	1,238,000,000	0	0	744,000,000	0				0	0	-2,000,000	1,090,000,000							0	-6,000,000	991,000,000							0
repayments of senior notes				-14,000,000				-1,370,000,000	-289,000,000	-60,000,000
repayments from issuance of commercial paper	-1,000,000	-4,000,000							415,000,000	-177,000,000
debt issue costs	-2,000,000	-3,000,000	0	0	-2,000,000	-5,000,000	-3,000,000	0	0	-4,000,000	-4,000,000	0	-1,000,000	-1,000,000	-2,000,000	-8,000,000
change in book overdraft	-72,000,000	-33,000,000	47,000,000	1,000,000	22,000,000	-20,000,000	107,000,000	-211,000,000	51,000,000	108,000,000	61,000,000	-154,000,000	74,000,000	-9,000,000	86,000,000	4,000,000	-107,000,000	23,000,000	106,000,000	-96,000,000	140,000,000	-55,000,000	69,000,000	50,000,000	-17,000,000	125,000,000	-50,000,000	-17,000,000	54,000,000	-61,000,000	-34,000,000	-9,000,000	-65,000,000	-44,000,000	-13,000,000	21,000,000	-46,000,000	67,000,000	-27,000,000	27,000,000	-136,000,000	130,000,000	27,000,000	-44,000,000	-34,000,000	47,000,000	17,000,000	-34,000,000	-12,000,000	7,798,000	81,300,000	-34,786,000	-157,312,000	168,156,000	1,313,000	3,878,000	-138,426,000	175,080,000	45,531,000	-104,209,000	33,520,000
common stock repurchases	-100,000,000	-9,000,000	-49,000,000	-2,000,000	-49,000,000	-717,000,000	-571,000,000	-379,000,000	-529,000,000	-94,000,000	-1,064,000,000	-4,000,000	-4,000,000	-1,024,000,000	-43,000,000	-3,000,000	-3,000,000	-30,000,000	-1,790,000,000	-5,000,000	-8,000,000	-17,000,000	-1,000,000,000	0	-10,000,000	-201,000,000	-42,000,000	-51,000,000	-241,000,000	-4,000,000	-1,574,000,000	-2,000,000	-2,000,000	-71,000,000	-9,000,000	-305,000,000	-66,000,000	-602,000,000	-118,000,000	-103,000,000	-49,000,000	-206,000,000	-94,000,000	-137,000,000	-94,000,000	-5,000,000	-235,000,000	-127,000,000	-151,000,000	-766,000	-239,446,000	-211,884,000	-88,904,000	-375,000	-50,301,000	-50,199,000	-7,670,000	-14,571,000	-2,271,000	0	-5,999,000
dividends paid	-106,000,000	-108,000,000	-108,000,000	-107,000,000	-107,000,000	-109,000,000	-111,000,000	-109,000,000	-111,000,000	-100,000,000	-101,000,000	-100,000,000	-100,000,000	-91,000,000	-91,000,000	-90,000,000	-90,000,000	-83,000,000	-84,000,000	-83,000,000	-83,000,000	-73,000,000	-74,000,000	-74,000,000	-68,000,000	-69,000,000	-69,000,000	-57,000,000	-58,000,000	-57,000,000	-47,000,000	-43,000,000	-43,000,000	-47,000,000	-43,000,000	-42,000,000	-44,000,000	-43,000,000	-43,000,000	-42,000,000	-44,000,000	-43,000,000	-42,000,000	-41,000,000	-42,000,000	-41,000,000	-42,000,000	-41,000,000	-41,000,000	-40,506,000
changes in securities lending payable	-127,000,000	175,000,000
changes in rebate factor payable	-55,000,000	-68,000,000
net cash from financing activities	-1,828,000,000	1,384,000,000	-2,304,000,000	-770,000,000	-620,000,000	1,207,000,000	-2,438,000,000	-1,733,000,000	36,000,000	3,279,000,000	-2,358,000,000	-1,791,000,000	419,000,000	1,816,000,000	-712,000,000	2,342,000,000	-144,000,000	1,529,000,000	-3,540,000,000	-845,000,000	-306,000,000	2,736,000,000	-1,127,000,000	-477,000,000	493,000,000	-1,281,000,000	-17,000,000	1,532,000,000	-439,000,000	-28,000,000	1,269,000,000	74,000,000	-227,000,000	176,000,000	-1,080,000,000	-404,000,000	-2,000,000	-1,268,000,000	930,000,000	-444,000,000	24,000,000	-62,000,000	-416,000,000	-296,000,000	72,000,000	950,000,000	-758,000,000	-344,000,000	123,000,000	-630,485,000	-183,386,000	-181,308,000	-21,821,000	-256,419,000	-92,410,000	4,602,000	-27,029,000	276,554,000	-48,093,000	-299,674,000	152,057,000
increase in cash and cash equivalents	-210,000,000	2,029,000,000	-2,895,000,000	-385,000,000	-409,000,000	1,216,000,000	-10,454,000,000	-1,066,000,000	2,479,000,000	8,674,000,000	-8,497,000,000	8,338,000,000	356,000,000	1,470,000,000	-910,000,000	926,000,000	-499,000,000	-796,000,000	-3,312,000,000	822,000,000	1,109,000,000	2,000,000,000	749,000,000	901,000,000	1,534,000,000	-4,689,000,000	-24,000,000	4,813,000,000	1,726,000,000	-286,000,000	4,548,000,000	4,340,000,000	-372,000,000	230,000,000	-653,000,000	304,000,000	11,000,000	-770,000,000	1,112,000,000	-69,000,000	524,000,000			121,000,000	92,000,000	-57,000,000	-2,506,000,000	213,000,000	2,279,000,000	-2,642,268,000	2,451,581,000	-188,217,000	82,904,000	-1,249,715,000	923,870,000	184,989,000	200,405,000
cash and cash equivalents at beginning of period	0	2,221,000,000	0	0	0	4,694,000,000	0	0	0	5,061,000,000	0	0	0	3,394,000,000	0	0	0	4,673,000,000	0	0	0	4,054,000,000	0	0	2,343,000,000	0	0	4,042,000,000	0	0	3,877,000,000	0	0	2,571,000,000	0	0	1,935,000,000		0	0	1,138,000,000		0	0	1,306,000,000		0	0	1,377,000,000		0	0	1,673,137,000		0	0	1,613,588,000		0	0	1,970,423,000
cash and cash equivalents at end of period	-210,000,000	4,250,000,000	-2,895,000,000	-385,000,000	-409,000,000	5,910,000,000	-10,454,000,000	-1,066,000,000	2,479,000,000	13,735,000,000	-8,497,000,000	8,338,000,000	356,000,000	4,864,000,000	-910,000,000	926,000,000	-499,000,000	3,877,000,000	-3,312,000,000	822,000,000	1,109,000,000	6,054,000,000	749,000,000	901,000,000	3,877,000,000	-4,689,000,000	-24,000,000	8,855,000,000	1,726,000,000	-286,000,000	8,425,000,000	4,340,000,000	-372,000,000	2,801,000,000	-653,000,000	304,000,000	1,946,000,000		1,112,000,000	-69,000,000	1,662,000,000		-264,000,000	121,000,000	1,398,000,000		-2,506,000,000	213,000,000	3,656,000,000		2,451,581,000	-188,217,000	1,756,041,000		923,870,000	184,989,000	1,813,993,000		-133,103,000	-326,093,000	1,911,202,000
gain on sale of gentiva hospice
(gain) loss on investment securities			-14,000,000			-1,000,000
deferred income taxes
changes in operating assets and liabilities, net of effect of businesses acquired and dispositions:
proceeds from sale of gentiva hospice
proceeds from sale of property and equipment
repayment of senior notes
(repayments) proceeds from issuance of commercial paper											284,000,000	-242,000,000	-153,000,000	-265,000,000									-2,000,000
proceeds from short-term borrowings
repayment of short-term borrowings
repayment of term loan							0	0	0	-500,000,000	0				-1,928,000,000
(repayments) issuance of commercial paper				0
loss on investment securities							5,000,000	4,000,000	-15,000,000	60,000,000
receipts from contract deposits					-214,000,000	499,000,000		-1,029,000,000	513,000,000	2,997,000,000		711,000,000	601,000,000	2,475,000,000			168,000,000	1,015,000,000			-185,000,000	574,000,000	-462,000,000	-81,000,000	554,000,000	-1,137,000,000	114,000,000	1,401,000,000	-150,000,000	351,000,000	1,730,000,000
repayments of commercial paper						-644,000,000
gain on kindred at home equity method investment															0
impairment of intangible assets
receipts (withdrawals) from contract deposits																																129,000,000	-97,000,000	318,000,000	-725,000,000	-382,000,000	123,000,000	-176,000,000	-616,000,000	-347,000,000	220,000,000	51,000,000	-333,000,000	-104,000,000	236,000,000	-50,000,000	-499,000,000	-146,000,000	298,000,000
proceeds (repayments) from issuance of commercial paper																			274,000,000	0
proceeds from term loan															2,000,000,000				0	0	0	1,000,000,000
proceeds from issuance (repayments) of commercial paper
impairment on property and equipment												4,000,000
gain on sale of kah hospice											3,000,000
benefit for deferred income taxes																				0	0	-3,000,000	0	0	-21,000,000	469,000,000			-56,000,000				-39,000,000	15,000,000	41,000,000	30,000,000	-58,000,000	-34,000,000	9,000,000	-13,000,000	-26,000,000	11,000,000	39,000,000	-8,000,000	0	-74,000,000	3,000,000	0	-9,000,000		-9,316,000	-5,934,000	27,352,000		-34,656,000	-60,405,000	-20,862,000		12,072,000
proceeds from sale of kah hospice											-7,000,000
equity in net earnings															4,000,000	-15,000,000	-33,000,000	-21,000,000	-6,000,000	-35,000,000	-25,000,000	-8,000,000
losses (gains) on investment securities													61,000,000	76,000,000
benefit from deferred income taxes																												83,000,000			29,000,000																														19,687,000
changes in operating assets and liabilities, net of effect of businesses acquired:
stock compensation
withdrawals receipts from contract deposits
proceeds from stock option exercises & other
proceeds from issuance of commercial paper																-315,000,000	-95,000,000	603,000,000				198,000,000			17,000,000			245,000,000			169,000,000				-290,000,000
proceeds from stock option exercises and other																-2,000,000	4,000,000	1,000,000		2,000,000	9,000,000	19,000,000	5,000,000	1,000,000	17,000,000	4,000,000	32,000,000	11,000,000	7,000,000	20,000,000	34,000,000				-1,000,000	3,000,000	18,000,000	-16,000,000	0	20,000,000	25,000,000	4,000,000	20,000,000	31,000,000	5,000,000	8,000,000	1,000,000	3,000,000	45,000,000	15,470,000	2,272,000	55,258,000	55,000,000	4,825,000	4,005,000	2,179,000	5,080,000	12,373,000	3,544,000	55,000	1,234,000
gains on investment securities																	-76,000,000	-10,000,000	-142,000,000
acquisitions, net of cash acquired																	-202,000,000	-123,000,000	0	0	0	-709,000,000				0	-185,000,000	-169,000,000	-1,000,000	-2,000,000	-7,000,000	-6,000,000			0			-15,000,000	0	3,000,000	-6,000,000	-26,000,000	-149,000,000	-7,000,000	-5,000,000	-947,000,000	-212,000,000	-20,000,000	-56,000,000	-212,348,000	-2,700,000	-5,952,000	-5,000,000	-822,330,000	-8,451,000	-1,669,000	0	0	-69,000	0	-12,367,000
maturities of investment securities																	935,000,000	692,000,000	1,486,000,000	1,855,000,000	910,000,000	735,000,000	387,000,000	497,000,000	397,000,000	260,000,000	338,000,000	217,000,000	270,000,000	365,000,000	284,000,000	447,000,000	422,000,000	213,000,000	266,000,000	285,000,000	330,000,000	183,000,000	190,000,000	254,000,000	258,000,000	224,000,000	304,000,000	255,000,000	294,000,000	386,000,000	354,000,000	333,000,000	424,000,000	484,938,000	352,858,000	332,404,000	398,800,000	257,200,000	478,569,000	580,244,000	433,788,000	468,194,000	197,796,000	199,584,000	404,951,000
supplemental cash flow disclosures:
interest payments																	92,000,000	40,000,000		44,000,000	75,000,000	40,000,000	26,000,000	81,000,000	29,000,000	22,000,000	76,000,000	22,000,000	32,000,000	82,000,000	10,000,000	10,000,000	82,000,000	10,000,000	10,000,000	86,000,000	9,000,000	60,000,000	10,000,000	63,000,000	10,000,000	64,000,000	10,000,000	62,000,000	10,000,000	45,000,000	10,000,000	44,000,000	11,000,000	46,106,000	10,936,000	45,858,000	11,100,000	45,445,000	10,548,000	45,369,000	10,486,000	45,357,000	10,540,000	45,692,000	10,943,000
income tax payments																	387,000,000	-1,000,000		742,000,000			232,000,000			106,000,000			512,000,000			315,000,000	531,000,000	5,000,000	302,000,000	710,000,000	26,000,000	178,000,000	251,000,000	589,000,000	12,000,000	10,000,000	213,000,000	510,000,000	1,000,000	231,000,000	221,000,000	288,000,000	5,000,000	156,346,000	310,238,000	331,201,000	76,215,000	152,179,000	276,355,000	351,180,000	5,210,000	149,176,000	217,671,000	234,233,000	26,147,000
loss on sale of business
purchase of equity method investment in kindred at home
cash transferred in sale of business
withdrawals from contract deposits
(withdrawals) receipts from contract deposits
net realized capital gains																							-18,000,000			-8,000,000	-53,000,000	-29,000,000	0	-2,000,000	-26,000,000	-26,000,000	-19,000,000	-20,000,000	-51,000,000	-28,000,000	-9,000,000	-11,000,000	-6,000,000	-2,000,000	-1,000,000	-8,000,000	-4,000,000	-5,000,000	-5,000,000	-13,000,000	-6,000,000	-10,000,000	-4,000,000	-3,745,000	-2,146,000	-1,183,000	-3,926,000		-4,310,000	718,000	-8,694,000
net realized capital (gains) losses																						-49,000,000																																				-5,749,000
income tax refunds																						-6,000,000
equity in net earnings of kindred at home																							-1,000,000	-12,000,000	-3,000,000
acquisition, equity method investment in kindred at home
net realized capital losses																									2,000,000
income tax (refunds) payments																									-22,000,000						-4,000,000
other intangible amortization																										19,000,000	21,000,000	30,000,000	18,000,000	18,000,000	18,000,000	18,000,000	20,000,000	21,000,000	22,000,000	24,000,000	26,000,000
proceeds (repayment) from issuance of commercial paper																										-3,000,000
loss on business held-for-sale
income tax payments (refunds)																												4,000,000
repayment of commercial paper																													-51,000,000
gain on sale of business																																			0
proceeds from sale of business																																			0			0	0	0	72,000,000	1,000,000	0
proceeds (repayment) of commercial paper
excess tax benefit from stock-based compensation																																		20,000,000	1,000,000	1,000,000	13,000,000	2,000,000	1,000,000	1,000,000	8,000,000	2,000,000	6,000,000	-1,000,000	1,000,000	1,000,000	0	1,000,000	20,000,000	2,754,000	959,000	6,156,000	5,131,000	558,000	142,000	530,000	734,000	3,622,000	1,473,000	96,000	148,000
depreciation and amortization																																						124,000,000	112,000,000	106,000,000	107,000,000	114,000,000	106,000,000	104,000,000	102,000,000	100,000,000	78,000,000	82,000,000	78,000,000	77,836,000	74,581,000	75,092,000	75,491,000	66,307,000	64,557,000	69,290,000	62,756,000	69,694,000	62,088,000	60,478,000	58,014,000
benefit from doubtful accounts
proceeds from sales of property and equipment
repayment of long-term debt																																										0	0	0	0	0	0	0	-36,000,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
details of businesses acquired in purchase transactions:
fair value of assets acquired, net of cash acquired
less: fair value of liabilities assumed
cash paid for acquired businesses, net of cash acquired
decrease in cash and cash equivalents																																										-117,000,000																	-133,103,000	-326,093,000	-59,221,000
change in securities lending collateral																																																		9,789,000	24,054,000	1,461,000	18,696,000	-17,587,000	13,512,000	16,603,000	58,206,000	63,347,000	115,234,000	62,408,000	71,283,000
receipts from cms contract deposits																																																		381,679,000	880,474,000	640,938,000	613,909,000	437,343,000	439,622,000	442,144,000	438,108,000	819,609,000	499,987,000	505,677,000	528,965,000
withdrawals from cms contract deposits																																																		-985,125,000	-843,397,000	-635,529,000	-430,949,000	-876,736,000	-473,679,000	-377,327,000	-266,649,000	-656,212,000	-481,123,000	-388,885,000	-334,528,000
repayments under credit agreement																																																						0	0			0	0
change in securities lending payable																																																		-11,789,000	-24,054,000	-1,461,000	-18,696,000	17,587,000	-13,512,000	-16,603,000	-58,206,000	-63,347,000	-115,234,000	-62,408,000	-71,283,000
(gain) loss on sale of property and equipment
borrowings under credit agreement
proceeds from swap termination
gain on sale of property and equipment
gain on sale of investment securities																																																												-8,507,000	-1,043,000
tax benefit from stock-based compensation

We provide you with 20 years of cash flow statements for Humana stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Humana stock. Explore the full financial landscape of Humana stock with our expertly curated income statements.

The information provided in this report about Humana stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.